Globe Life (NYSE:GL) Releases FY24 Earnings Guidance

Globe Life (NYSE:GLGet Free Report) issued an update on its FY24 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $11.50-12.00 for the period, compared to the consensus estimate of $11.60. Globe Life also updated its FY 2024 guidance to 11.500-12.000 EPS.

Globe Life Stock Performance

Shares of GL stock opened at $66.39 on Tuesday. The business’s fifty day simple moving average is $110.58 and its 200-day simple moving average is $116.35. The company has a market cap of $6.24 billion, a PE ratio of 6.59 and a beta of 0.69. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.36. Globe Life has a 12-month low of $38.95 and a 12-month high of $132.00.

Globe Life (NYSE:GLGet Free Report) last issued its quarterly earnings results on Wednesday, February 7th. The company reported $2.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.73 by $0.15. The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.40 billion. Globe Life had a return on equity of 24.25% and a net margin of 17.82%. The business’s quarterly revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the firm posted $2.24 earnings per share. Analysts expect that Globe Life will post 11.6 earnings per share for the current fiscal year.

Globe Life Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Friday, April 5th will be given a dividend of $0.24 per share. The ex-dividend date is Thursday, April 4th. This is an increase from Globe Life’s previous quarterly dividend of $0.23. This represents a $0.96 dividend on an annualized basis and a dividend yield of 1.45%. Globe Life’s dividend payout ratio is presently 9.52%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on GL shares. StockNews.com downgraded Globe Life from a buy rating to a hold rating in a research report on Saturday. Piper Sandler cut their target price on Globe Life from $143.00 to $130.00 and set an overweight rating on the stock in a research report on Friday, April 5th. Truist Financial reissued a hold rating and issued a $125.00 target price on shares of Globe Life in a research report on Friday, April 12th. Evercore ISI cut their target price on Globe Life from $125.00 to $75.00 and set an in-line rating on the stock in a research report on Friday, April 12th. Finally, Keefe, Bruyette & Woods cut their target price on Globe Life from $135.00 to $130.00 and set a market perform rating on the stock in a research report on Wednesday, April 10th. Six equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of Moderate Buy and an average target price of $126.44.

View Our Latest Stock Analysis on Globe Life

About Globe Life

(Get Free Report)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Further Reading

Earnings History and Estimates for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.